GSK, Ashmore and Barratt Developments

Continuing worries over the potential economic impact of the coronavirus are already driving government policy decisions. European markets climbed to record levels after China cut tariffs, with Beijing moving to reduce levies as part of a new trade deal. No one can be sure about the extent to which the spread of the virus will drag on the global economy, but the fatality list is now into the hundreds, and with no clinical breakthrough in sight, there is bound to be a significant material impact beyond the tragic human cost.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now